Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202

BACKGROUND: In prostate cancer, end points that reliably portend prognosis and treatment benefit (surrogate end points) can accelerate therapy development. Although surrogate end point candidates have been evaluated in the context of radiotherapy and short-term androgen deprivation (AD), potential s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Dignam, James J., Hamstra, Daniel A., Lepor, Herbert, Grignon, David, Brereton, Harmar, Currey, Adam, Rosenthal, Seth, Zeitzer, Kenneth L., Venkatesan, Varagur M., Horwitz, Eric M., Pisansky, Thomas M., Sandler, Howard M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6338393/
https://ncbi.nlm.nih.gov/pubmed/30526194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00154
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados